178 related articles for article (PubMed ID: 31245283)
1. The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
Cheng F; Zhang P; Xiao Q; Li Y; Dong M; Wang H; Kuang D; He Y; Duan Q; Mao F; Wang B; Guo D
Front Oncol; 2019; 9():447. PubMed ID: 31245283
[TBL] [Abstract][Full Text] [Related]
2. LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor.
Guo D; Yang H; Guo Y; Xiao Q; Mao F; Tan Y; Wan X; Wang B; Lei T
J Neurol Sci; 2015 Mar; 350(1-2):61-8. PubMed ID: 25708990
[TBL] [Abstract][Full Text] [Related]
3. Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth.
Li Y; Wang W; Hou X; Huang W; Zhang P; He Y; Wang B; Duan Q; Mao F; Guo D
Cell Death Dis; 2023 Jan; 14(1):28. PubMed ID: 36639372
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15).
Cai M; Han L; Chen R; Ye F; Wang B; Han F; Lei T; Guo D
Cancer Lett; 2009 Jun; 278(1):104-12. PubMed ID: 19200647
[TBL] [Abstract][Full Text] [Related]
5. LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma.
Peng C; Chen H; Li Y; Yang H; Qin P; Ma B; Duan Q; Wang B; Mao F; Guo D
Front Oncol; 2021; 11():621154. PubMed ID: 33718179
[TBL] [Abstract][Full Text] [Related]
6. [LRIG3 gene regulates biological activity of GL15 cell line].
Xi GF; Wu Q; Wang BF; Guo DS; Chen G; Zhang JM; Lei T
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):444-50. PubMed ID: 18925709
[TBL] [Abstract][Full Text] [Related]
7. Effect of RNAi-mediated LRIG3 gene silencing on proliferation of glioma GL15 cells and expression of PCNA and Ki-67.
Cai MJ; Xie RF; Han L; Chen RD; Wang BF; Ye F; Guo DS; Lei T
Ai Zheng; 2009 Jan; 28(1):1-4. PubMed ID: 19448407
[TBL] [Abstract][Full Text] [Related]
8. Effects of RNAi-mediated gene silencing of LRIG3 expression on cell cycle and survival of glioma cells.
Cai M; Xie R; Han L; Chen R; Wang B; Ye F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):88-93. PubMed ID: 19224171
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
Cheng F; Zhang P; Xiao Q; Li Y; Dong M; Wang H; Kuang D; He Y; Duan Q; Mao F; Wang B; Guo D
Front Oncol; 2020; 10():591112. PubMed ID: 33102241
[TBL] [Abstract][Full Text] [Related]
10. Effect of over-expressed LRIG3 on cell cycle and survival of glioma cells.
Yang H; Mao F; Zhang H; Wang B; Wan F; Guo D; Lei T
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):667. PubMed ID: 22038358
[TBL] [Abstract][Full Text] [Related]
11. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma.
M Serag El-Dien M; Fathy Mahmoud S; Alhanafy AM; Mohamed Zanaty F; Shawky Holah N
J Immunoassay Immunochem; 2022 May; 43(3):308-332. PubMed ID: 34839782
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
Lindström AK; Hellberg D
Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
[TBL] [Abstract][Full Text] [Related]
14. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
15. LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease.
Karlsson T; Kvarnbrink S; Holmlund C; Botling J; Micke P; Henriksson R; Johansson M; Hedman H
Lung Cancer; 2018 Nov; 125():174-184. PubMed ID: 30429017
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed LRIG3 gene ameliorates prostate cancer through suppression of cell invasion and migration.
Chen Y; Wang Q; Wang M; Li M
Int J Biol Macromol; 2019 Mar; 124():1-9. PubMed ID: 30412760
[TBL] [Abstract][Full Text] [Related]
17. LRIG3 represses cell motility by inhibiting slug via inactivating ERK signaling in human colorectal cancer.
Zeng K; Chen X; Xu M; Liu X; Li C; Xu X; Pan B; Qin J; He B; Pan Y; Huiling S; Xu T; Wang S
IUBMB Life; 2020 Jul; 72(7):1393-1403. PubMed ID: 32107843
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.
Fukushima T; Kawaguchi M; Yamamoto K; Yamashita F; Izumi A; Kaieda T; Takezaki Y; Itoh H; Takeshima H; Kataoka H
Cancer Sci; 2018 Sep; 109(9):2970-2979. PubMed ID: 29987920
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
Liu M; Lin Y; Zhang XC; Tan YH; Yao YL; Tan J; Zhang X; Cui YH; Liu X; Wang Y; Bian XW
Lab Invest; 2017 Nov; 97(11):1354-1363. PubMed ID: 28759011
[TBL] [Abstract][Full Text] [Related]
20. Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
